Tapewire

Nasdaq · USD

ZSQR

Z Squared Inc.

Export transactions ↓
Tapewire entity
6495
SEC CIK
0001759186
Parsed reports
89

Last 12 months

Inside the activity.

2 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202620
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 27, 2026 Filed Apr 30, 2026 10:11 UTC
Schadel Christopher RyanChief Marketing Officer
GrantRestricted Stock Units · Derivative 9,868 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001683168-26-003326 · ownership.xml · derivative · entry 2

Schadel Christopher Ryan · CIK 0001550967 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,868

Underlying: Common Stock · 9,868 shares

Expires not disclosed

F2 · security: Iin addition, pursuant to the Employment Agreement, the issuer agreed to grant the reporting person an annual bonus of restricted stock units ("RSUs") having a grant-date fair market value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the closing price per share of the common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share). The RSUs vest in equal quarterly installments over one year commencing on April 27, 2026, subject to the reporting person's continued employment with the issuer on each vesting date.

F2 · derivative.exercise_date: Iin addition, pursuant to the Employment Agreement, the issuer agreed to grant the reporting person an annual bonus of restricted stock units ("RSUs") having a grant-date fair market value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the closing price per share of the common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share). The RSUs vest in equal quarterly installments over one year commencing on April 27, 2026, subject to the reporting person's continued employment with the issuer on each vesting date.

F2 · derivative.expiration_date: Iin addition, pursuant to the Employment Agreement, the issuer agreed to grant the reporting person an annual bonus of restricted stock units ("RSUs") having a grant-date fair market value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the closing price per share of the common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share). The RSUs vest in equal quarterly installments over one year commencing on April 27, 2026, subject to the reporting person's continued employment with the issuer on each vesting date.

Read SEC document
April 27, 2026 Filed Apr 30, 2026 10:11 UTC
Schadel Christopher RyanChief Marketing Officer
GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $15.20 $0.00
Disclosure

SEC source: 0001683168-26-003326 · ownership.xml · derivative · entry 1

Schadel Christopher Ryan · CIK 0001550967 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2036-04-27

F1 · security: On April 27, 2026, the issuer and the reporting person entered into an Executive Employment Agreement (the "Employment Agreement"), pursuant to which the issuer agreed to grant the reporting person an option to purchase 100,000 shares of common stock at an exercise price equal to the fair market value of the common stock on the grant date. The Stock Option was granted pursuant to Section 3(c) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. The Stock Option vests in full on the date the fair market value of the common stock increases by 50% above the grant-date fair market value, as determined by the Board in its reasonable discretion, and remains exercisable for ten (10) years from the grant date, subject to earlier termination under the 2025 Plan and applicable award agreement.

F1 · derivative.exercise_date: On April 27, 2026, the issuer and the reporting person entered into an Executive Employment Agreement (the "Employment Agreement"), pursuant to which the issuer agreed to grant the reporting person an option to purchase 100,000 shares of common stock at an exercise price equal to the fair market value of the common stock on the grant date. The Stock Option was granted pursuant to Section 3(c) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. The Stock Option vests in full on the date the fair market value of the common stock increases by 50% above the grant-date fair market value, as determined by the Board in its reasonable discretion, and remains exercisable for ten (10) years from the grant date, subject to earlier termination under the 2025 Plan and applicable award agreement.

Read SEC document
April 27, 2026 Filed Apr 30, 2026 10:13 UTC GrantRestricted Stock Units · Derivative 9,868 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001683168-26-003328 · ownership.xml · derivative · entry 1

Sohn Adam Craig · CIK 0002113700 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,868

Underlying: Common Stock · 9,868 shares

Expires not disclosed

F1 · security: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date.

F1 · derivative.exercise_date: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date.

F1 · derivative.expiration_date: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date.

Read SEC document
April 27, 2026 Filed Apr 30, 2026 10:10 UTC
Halabu David EliasDirector · Co-Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $15.20 $0.00
Disclosure

SEC source: 0001683168-26-003324 · ownership.xml · derivative · entry 1

Halabu David Elias · CIK 0002110997 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2036-04-27

F1 · security: On April 27, 2026, the issuer and the reporting person entered into an Amended and Restated Executive Employment Agreement (the "A&R Agreement"), pursuant to which the issuer agreed to grant the reporting person an option to purchase 500,000 shares of common stock at an exercise price equal to the fair market value of the common stock on the grant date. The Stock Option was granted pursuant to Section 3(d) of the A&R Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. The Stock Option vests in full on the date the fair market value of the common stock increases by 50% above the grant-date fair market value, as determined by the Board in its reasonable discretion, and remains exercisable for ten (10) years from the grant date, subject to earlier termination under the 2025 Plan and applicable award agreement.

F1 · derivative.exercise_date: On April 27, 2026, the issuer and the reporting person entered into an Amended and Restated Executive Employment Agreement (the "A&R Agreement"), pursuant to which the issuer agreed to grant the reporting person an option to purchase 500,000 shares of common stock at an exercise price equal to the fair market value of the common stock on the grant date. The Stock Option was granted pursuant to Section 3(d) of the A&R Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. The Stock Option vests in full on the date the fair market value of the common stock increases by 50% above the grant-date fair market value, as determined by the Board in its reasonable discretion, and remains exercisable for ten (10) years from the grant date, subject to earlier termination under the 2025 Plan and applicable award agreement.

Read SEC document
April 27, 2026 Filed Apr 30, 2026 10:08 UTC GrantRestricted Stock Units · Derivative 9,868 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001683168-26-003322 · ownership.xml · derivative · entry 1

Fuerst Bryan Eric · CIK 0002111012 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,868

Underlying: Common Stock · 9,868 shares

Expires not disclosed

F1 · security: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date.

F1 · derivative.exercise_date: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date.

F1 · derivative.expiration_date: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date.

Read SEC document
April 27, 2026 Filed Apr 30, 2026 10:07 UTC GrantRestricted Stock Units · Derivative 9,868 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001683168-26-003320 · ownership.xml · derivative · entry 1

Cooper Kenneth Lyle · CIK 0002111618 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,868

Underlying: Common Stock · 9,868 shares

Expires not disclosed

F1 · security: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date.

F1 · derivative.exercise_date: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date.

F1 · derivative.expiration_date: On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date.

Read SEC document
April 27, 2026 Filed Apr 30, 2026 10:05 UTC
Burke Michelle EllenDirector · Co-Chief Executive Officer
GrantCommon Stock 16,447 $0.00 $0.00
Disclosure

SEC source: 0001683168-26-003316 · ownership.xml · nonDerivative · entry 1

Burke Michelle Ellen · CIK 0002114401 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,447

F1 · security: On April 27, 2026, the issuer entered into an Amendment to Service Agreement with the reporting person, pursuant to which the issuer agreed to issue $1,000,000 worth of shares of the issuer's common stock to the reporting person, payable in four equal quarterly tranches. The shares reported herein represent the first such tranche, issued pursuant to the Z Squared, Inc. 2025 Incentive Compensation Plan. The number of shares reported was determined by dividing $250,000 by the closing price per share of the issuer's common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share).

Read SEC document
April 27, 2026 Filed Aug 20, 2026 10:01 UTC
Schadel Christopher RyanChief Marketing Officer
GrantRestricted Stock Units · Derivative 9,868 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001185185-26-003631 · ownership.xml · derivative · entry 4

Schadel Christopher Ryan · CIK 0001550967 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,868

Underlying: Common Stock · 9,868 shares

Expires not disclosed

F3 · security: In addition, pursuant to the Employment Agreement, the issuer agreed to grant the reporting person an annual bonus of restricted stock units ("RSUs") having a grant-date fair market value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the closing price per share of the common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share). The RSUs vest in equal quarterly installments over one year commencing on April 27, 2026, subject to the reporting person's continued employment with the issuer on each vesting date.

F3 · derivative.exercise_date: In addition, pursuant to the Employment Agreement, the issuer agreed to grant the reporting person an annual bonus of restricted stock units ("RSUs") having a grant-date fair market value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the closing price per share of the common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share). The RSUs vest in equal quarterly installments over one year commencing on April 27, 2026, subject to the reporting person's continued employment with the issuer on each vesting date.

F3 · derivative.expiration_date: In addition, pursuant to the Employment Agreement, the issuer agreed to grant the reporting person an annual bonus of restricted stock units ("RSUs") having a grant-date fair market value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the closing price per share of the common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share). The RSUs vest in equal quarterly installments over one year commencing on April 27, 2026, subject to the reporting person's continued employment with the issuer on each vesting date.

Read SEC document
April 27, 2026 Filed Aug 20, 2026 10:01 UTC
Schadel Christopher RyanChief Marketing Officer
GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $15.20 $0.00
Disclosure

SEC source: 0001185185-26-003631 · ownership.xml · derivative · entry 3

Schadel Christopher Ryan · CIK 0001550967 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2036-04-27

F2 · security: On April 27, 2026, the issuer and the reporting person entered into an Executive Employment Agreement (the "Employment Agreement"), pursuant to which the issuer agreed to grant the reporting person an option to purchase 100,000 shares of common stock at an exercise price equal to the fair market value of the common stock on the grant date. The Stock Option was granted pursuant to Section 3(c) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. The Stock Option vests in full on the date the fair market value of the common stock increases by 50% above the grant-date fair market value, as determined by the Board in its reasonable discretion, and remains exercisable for ten (10) years from the grant date, subject to earlier termination under the 2025 Plan and applicable award agreement.

F2 · derivative.exercise_date: On April 27, 2026, the issuer and the reporting person entered into an Executive Employment Agreement (the "Employment Agreement"), pursuant to which the issuer agreed to grant the reporting person an option to purchase 100,000 shares of common stock at an exercise price equal to the fair market value of the common stock on the grant date. The Stock Option was granted pursuant to Section 3(c) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. The Stock Option vests in full on the date the fair market value of the common stock increases by 50% above the grant-date fair market value, as determined by the Board in its reasonable discretion, and remains exercisable for ten (10) years from the grant date, subject to earlier termination under the 2025 Plan and applicable award agreement.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 17:00 UTC
Cogley BrianChief Financial Officer
GrantCommon Stock 12,500 $0.00 $0.00
Disclosure

SEC source: 0001683168-26-001032 · ownership.xml · nonDerivative · entry 2

Cogley Brian · CIK 0002008384 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,500

F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 17:00 UTC
Cogley BrianChief Financial Officer
Exercise / conversionCommon stock 10,000 $10.56 $105,600.00
Disclosure

SEC source: 0001683168-26-001032 · ownership.xml · nonDerivative · entry 1

Cogley Brian · CIK 0002008384 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents the exercise price of shares purchased upon exercise of stock options.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 22:00 UTC
Salkind GeneDirector
GrantCommon Stock 3,250 $0.00 $0.00
Disclosure

SEC source: 0001683168-26-001025 · ownership.xml · nonDerivative · entry 2

Salkind Gene · CIK 0001592481 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,161

F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock.

F3 · ownership.direct: Includes 4,211 shares of common stock that are held as JTWROS with Catherine Salkind.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 22:00 UTC
Salkind GeneDirector
Exercise / conversionCommon stock 5,700 $10.56 $60,192.00
Disclosure

SEC source: 0001683168-26-001025 · ownership.xml · nonDerivative · entry 1

Salkind Gene · CIK 0001592481 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,161

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents the exercise price of shares purchased upon exercise of stock options.

F3 · ownership.direct: Includes 4,211 shares of common stock that are held as JTWROS with Catherine Salkind.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 17:00 UTC GrantCommon Stock 3,250 $0.00 $0.00
Disclosure

SEC source: 0001683168-26-001031 · ownership.xml · nonDerivative · entry 2

Deschamps Philippe · CIK 0001638231 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,950

F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 17:00 UTC Exercise / conversionCommon stock 5,700 $10.56 $60,192.00
Disclosure

SEC source: 0001683168-26-001031 · ownership.xml · nonDerivative · entry 1

Deschamps Philippe · CIK 0001638231 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,950

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents the exercise price of shares purchased upon exercise of stock options.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 22:00 UTC
Calise ChrisDirector
GrantCommon stock 3,250 $0.00 $0.00
Disclosure

SEC source: 0001683168-26-001030 · ownership.xml · nonDerivative · entry 2

Calise Chris · CIK 0001824769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 368,741

F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock.

F3 · ownership.direct: Includes (i) 49,500 shares of common stock that are owned by CJC Investment Trust (a Trust in which Mr. Calise is a control person), and (ii) 47,106 shares of common stock that are issuable under currently exercisable warrants.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 22:00 UTC
Calise ChrisDirector
Exercise / conversionCommon stock 5,700 $10.56 $60,192.00
Disclosure

SEC source: 0001683168-26-001030 · ownership.xml · nonDerivative · entry 1

Calise Chris · CIK 0001824769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 368,741

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents the exercise price of shares purchased upon exercise of stock options.

F3 · ownership.direct: Includes (i) 49,500 shares of common stock that are owned by CJC Investment Trust (a Trust in which Mr. Calise is a control person), and (ii) 47,106 shares of common stock that are issuable under currently exercisable warrants.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 22:00 UTC
Mehalick DavidDirector · CEO and President · 10% owner
GrantCommon Stock 51,250 $0.00 $0.00
Disclosure

SEC source: 0001683168-26-001029 · ownership.xml · nonDerivative · entry 2

Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 330,192

F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 22:00 UTC
Mehalick DavidDirector · CEO and President · 10% owner
Exercise / conversionCommon stock 148,875 $7.05 $1,049,568.75
Disclosure

SEC source: 0001683168-26-001029 · ownership.xml · nonDerivative · entry 1

Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 330,192

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents the weighted average exercise price of shares purchased upon exercise of stock options.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 22:00 UTC GrantCommon Stock 3,250 $0.00 $0.00
Disclosure

SEC source: 0001683168-26-001026 · ownership.xml · nonDerivative · entry 2

Cochran Christopher P. · CIK 0001951916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,950

F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 22:00 UTC Exercise / conversionCommon stock 5,700 $10.56 $60,192.00
Disclosure

SEC source: 0001683168-26-001026 · ownership.xml · nonDerivative · entry 1

Cochran Christopher P. · CIK 0001951916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,950

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents the exercise price of shares purchased upon exercise of stock options.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 22:00 UTC
Yerace Daniel AlexanderDirector · VP Operations
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001683168-26-001028 · ownership.xml · nonDerivative · entry 2

Yerace Daniel Alexander · CIK 0001846625 · Director · VP Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,531

F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 22:00 UTC
Yerace Daniel AlexanderDirector · VP Operations
Exercise / conversionCommon stock 10,000 $10.41 $104,100.00
Disclosure

SEC source: 0001683168-26-001028 · ownership.xml · nonDerivative · entry 1

Yerace Daniel Alexander · CIK 0001846625 · Director · VP Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents the weighted average exercise price of shares purchased upon exercise of stock options.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 22:00 UTC
DeSilva TaraDirector
GrantCommon Stock 3,250 $0.00 $0.00
Disclosure

SEC source: 0001683168-26-001027 · ownership.xml · nonDerivative · entry 2

DeSilva Tara · CIK 0001952535 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,950

F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 22:00 UTC
DeSilva TaraDirector
Exercise / conversionCommon stock 5,700 $10.56 $60,192.00
Disclosure

SEC source: 0001683168-26-001027 · ownership.xml · nonDerivative · entry 1

DeSilva Tara · CIK 0001952535 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,950

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents the exercise price of shares purchased upon exercise of stock options.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 22:00 UTC
Sheehy Christine EliseVP Compliance and Secy
GrantCommon Stock 12,500 $0.00 $0.00
Disclosure

SEC source: 0001683168-26-001024 · ownership.xml · nonDerivative · entry 2

Sheehy Christine Elise · CIK 0001846632 · VP Compliance and Secy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,031

F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 22:00 UTC
Sheehy Christine EliseVP Compliance and Secy
Exercise / conversionCommon stock 1,000 $10.56 $10,560.00
Disclosure

SEC source: 0001683168-26-001024 · ownership.xml · nonDerivative · entry 1

Sheehy Christine Elise · CIK 0001846632 · VP Compliance and Secy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,031

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents the exercise price of shares purchased upon exercise of stock options.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 17:29 UTC
Cogley BrianChief Financial Officer
GrantNon-Qualified Stock Options (right to buy) · Derivative 10,000 Not disclosed Strike: $10.56 Not disclosed
Disclosure

SEC source: 0001683168-25-001395 · ownership.xml · derivative · entry 1

Cogley Brian · CIK 0002008384 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F1 · security: On March 4, 2025, the reporting person received a grant of 10,000 non-qualified stock options, under the 2022 equity incentive plan.

F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F3 · derivative.exercise_date: Options will vest over 4 years, in equal quarterly installments over such period, with the final options vesting on 12/31/28.

F4 · derivative.expiration_date: Expiration date is ten years from the day of grant.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 22:28 UTC
Salkind GeneDirector
GrantNon-qualified Stock Options (right to buy) · Derivative 5,700 Not disclosed Strike: $10.56 Not disclosed
Disclosure

SEC source: 0001683168-25-001392 · ownership.xml · derivative · entry 1

Salkind Gene · CIK 0001592481 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,950

Underlying: Common Stock · 5,700 shares

Expires not disclosed

F1 · security: On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan.

F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25.

F4 · derivative.expiration_date: Expiration date is ten years from the day of grant.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 22:29 UTC
Yerace Daniel AlexanderDirector · VP of Operations
GrantNon-Qualified Stock Options (right to buy) · Derivative 5,000 Not disclosed Strike: $10.56 Not disclosed
Disclosure

SEC source: 0001683168-25-001394 · ownership.xml · derivative · entry 1

Yerace Daniel Alexander · CIK 0001846625 · Director · VP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 1,000 shares

Expires not disclosed

F1 · security: On March 4, 2025, the reporting person received a grant of 5,000 non-qualified stock options, under the 2022 equity incentive plan.

F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F3 · derivative.exercise_date: Options will vest over 4 years, in equal quarterly installments over such period, with the final options vesting on 12/31/28.

F4 · derivative.expiration_date: Expiration date is ten years from the day of grant.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 22:28 UTC
Sheehy Christine EliseVP Compliance and Secy
GrantNon-Qualified Stock Options (right to buy) · Derivative 1,000 Not disclosed Strike: $10.56 Not disclosed
Disclosure

SEC source: 0001683168-25-001393 · ownership.xml · derivative · entry 1

Sheehy Christine Elise · CIK 0001846632 · VP Compliance and Secy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

Underlying: Common Stock · 1,000 shares

Expires not disclosed

F1 · security: On March 4, 2025, the reporting person received a grant of 1,000 non-qualified stock options, under the 2022 equity incentive plan.

F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F3 · derivative.exercise_date: Options will vest over 4 years, in equal quarterly installments over such period, with the final options vesting on 12/31/28.

F4 · derivative.expiration_date: Expiration date is ten years from the day of grant.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 22:27 UTC
Mehalick DavidDirector · CEO and President · 10% owner
GrantNon-Qualified Stock Options (right to buy) · Derivative 28,875 Not disclosed Strike: $10.56 Not disclosed
Disclosure

SEC source: 0001683168-25-001391 · ownership.xml · derivative · entry 1

Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,125

Underlying: Common Stock · 28,875 shares

Expires not disclosed

F1 · security: On March 4, 2025, the reporting person received a grant of 28,875 non-qualified stock options, under the 2022 equity incentive plan.

F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F3 · derivative.exercise_date: Options will vest over 4 years, in equal quarterly installments over such period, with the final options vesting on 12/31/28.

F4 · derivative.expiration_date: Expiration date is ten years from the day of grant.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 22:27 UTC
DeSilva TaraDirector
GrantNon-qualified Stock Options (right to buy) · Derivative 5,700 Not disclosed Strike: $10.56 Not disclosed
Disclosure

SEC source: 0001683168-25-001390 · ownership.xml · derivative · entry 1

DeSilva Tara · CIK 0001952535 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,950

Underlying: Common Stock · 5,700 shares

Expires not disclosed

F1 · security: On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan.

F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25.

F4 · derivative.expiration_date: Expiration date is ten years from the day of grant.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 22:26 UTC GrantNon-qualified Stock Options (right to buy) · Derivative 5,700 Not disclosed Strike: $10.56 Not disclosed
Disclosure

SEC source: 0001683168-25-001389 · ownership.xml · derivative · entry 1

Cochran Christopher P. · CIK 0001951916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,950

Underlying: Common Stock · 5,700 shares

Expires not disclosed

F1 · security: On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan.

F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25.

F4 · derivative.expiration_date: Expiration date is ten years from the day of grant.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 22:26 UTC
Calise ChrisDirector
GrantNon-qualified Stock Options (right to buy) · Derivative 5,700 Not disclosed Strike: $10.56 Not disclosed
Disclosure

SEC source: 0001683168-25-001388 · ownership.xml · derivative · entry 1

Calise Chris · CIK 0001824769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,950

Underlying: Common Stock · 5,700 shares

Expires not disclosed

F1 · security: On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan.

F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25.

F4 · derivative.expiration_date: Expiration date is ten years from the day of grant.

Read SEC document
March 04, 2025 Filed Mar 10, 2025 21:23 UTC GrantNon-qualified Stock Options (right to buy) · Derivative 5,700 Not disclosed Strike: $10.56 Not disclosed
Disclosure

SEC source: 0001683168-25-001475 · ownership.xml · derivative · entry 1

Deschamps Philippe · CIK 0001638231 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,950

Underlying: Common Stock · 5,700 shares

Expires not disclosed

F1 · security: On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan.

F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.

F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25.

F4 · derivative.expiration_date: Expiration date is ten years from the day of grant.

Read SEC document
January 12, 2024 Filed Jan 17, 2024 01:14 UTC
DeSilva TaraDirector
PurchaseCommon Stock 1,800 $0.58 $1,044.00
Disclosure

SEC source: 0001683168-24-000319 · ownership.xml · nonDerivative · entry 2

DeSilva Tara · CIK 0001952535 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,266

F1 · balance_after: Includes 30,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days.

Read SEC document
January 12, 2024 Filed Jan 17, 2024 01:14 UTC
DeSilva TaraDirector
PurchaseCommon Stock 466 $0.56 $260.96
Disclosure

SEC source: 0001683168-24-000319 · ownership.xml · nonDerivative · entry 1

DeSilva Tara · CIK 0001952535 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,466

F1 · balance_after: Includes 30,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days.

Read SEC document
January 10, 2024 Filed Jan 17, 2024 16:03 UTC
Cogley BrianChief Financial Officer
PurchaseCommon Stock 5,000 $0.67 $3,350.00
Disclosure

SEC source: 0001683168-24-000329 · ownership.xml · nonDerivative · entry 1

Cogley Brian · CIK 0002008384 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

F1 · balance_after: Includes 25,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days.

Read SEC document
January 08, 2024 Filed Jan 9, 2024 22:30 UTC
Mehalick DavidDirector · CEO and President · 10% owner
PurchaseCommon Stock 14,004 $0.66 $9,242.64
Disclosure

SEC source: 0001683168-24-000159 · ownership.xml · nonDerivative · entry 3

Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,782,615

F1 · balance_after: Includes 156,250 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. exercise of options that are or will become exercisable in the next 60 days.

Read SEC document
January 08, 2024 Filed Jan 9, 2024 22:30 UTC
Mehalick DavidDirector · CEO and President · 10% owner
PurchaseCommon Stock 6,000 $0.67 $4,020.00
Disclosure

SEC source: 0001683168-24-000159 · ownership.xml · nonDerivative · entry 2

Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,768,611

F1 · balance_after: Includes 156,250 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. exercise of options that are or will become exercisable in the next 60 days.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 22:31 UTC
Salkind GeneDirector
PurchaseCommon Stock 11,600 $0.69 $8,004.00
Disclosure

SEC source: 0001683168-24-000161 · ownership.xml · nonDerivative · entry 1

Salkind Gene · CIK 0001592481 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 284,056

F1 · balance_after: Includes (i) 95,817 shares of common stock that are held as JTWROS with Catherine Salkind, (ii) 57,268 shares of common stock issuable upon exercise of currently exercisable warrants held as JTWROS with Catherine Salkind, (iii) 101,061 shares of common stock that are issuable upon currently exercisable warrants and (iv) 30,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 22:32 UTC
Yerace Daniel AlexanderDirector · VP of Operations
PurchaseCommon Stock 10,850 $0.69 $7,486.50
Disclosure

SEC source: 0001683168-24-000163 · ownership.xml · nonDerivative · entry 1

Yerace Daniel Alexander · CIK 0001846625 · Director · VP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,071,455

F1 · balance_after: Includes 50,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 22:30 UTC
Mehalick DavidDirector · CEO and President · 10% owner
PurchaseCommon Stock 5,050 $0.69 $3,484.50
Disclosure

SEC source: 0001683168-24-000159 · ownership.xml · nonDerivative · entry 1

Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,762,611

F1 · balance_after: Includes 156,250 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. exercise of options that are or will become exercisable in the next 60 days.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 22:30 UTC PurchaseCommon Stock 7,000 $0.77 $5,390.00
Disclosure

SEC source: 0001683168-24-000157 · ownership.xml · nonDerivative · entry 1

Cochran Christopher P. · CIK 0001951916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,000

F1 · balance_after: Includes 30,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days.

Read SEC document
December 07, 2023 Filed Dec 11, 2023 21:01 UTC
Mehalick DavidDirector · CEO and President · 10% owner
GiftCommon Stock 700,000 $0.00 $0.00
Disclosure

SEC source: 0001683168-23-008778 · ownership.xml · nonDerivative · entry 1

Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,757,561

F1 · acquired: The listed shares were transferred to an estate planning trust that has an independent trustee, for the benefit of the Reporting Person's children and for no consideration. The Reporting Person does not serve as trustee of this trust nor does he have or share investment control over the listed shares held by this trust. The Reporting Person disclaims beneficial ownership of the shares held by the trust, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the listed shares for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.

Read SEC document
August 29, 2023 Filed Aug 30, 2023 19:15 UTC
Salkind GeneDirector
PurchaseCommon Stock 4,006 $1.01 $4,046.06
Disclosure

SEC source: 0001683168-23-006169 · ownership.xml · nonDerivative · entry 3

Salkind Gene · CIK 0001592481 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 4,046

F3 · ownership.nature: Julian R Salkind Trust DTD 10/11/94, for which the Reporting Person is the Trustee.

Read SEC document
August 25, 2023 Filed Aug 30, 2023 19:15 UTC
Salkind GeneDirector
PurchaseCommon Stock 28,638 $0.91 $26,060.58
Disclosure

SEC source: 0001683168-23-006169 · ownership.xml · nonDerivative · entry 1

Salkind Gene · CIK 0001592481 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 28,638

F1 · ownership.nature: The Marital Trust GST Subject U/W/O Leopold Salkind, for which the Reporting Person is the trustee.

Read SEC document
August 23, 2023 Filed Aug 31, 2023 20:01 UTC
Calise ChrisDirector
PurchaseCommon Stock 2,582 $0.94 $2,418.56
Disclosure

SEC source: 0001683168-23-006200 · ownership.xml · nonDerivative · entry 2

Calise Chris · CIK 0001824769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,464,897

F1 · balance_after: Includes (i) 942,117 shares of common stock that are issuable under currently exercisable options and (ii) 7,500 shares of common stock that are issuable upon exercise of options that will become exercisable. Does not include 22,500 shares of common stock that are issuable upon exercise of options that are not currently exercisable and will not become exercisable in the next 60 days.

Read SEC document
August 23, 2023 Filed Aug 31, 2023 20:01 UTC
Calise ChrisDirector
PurchaseCommon Stock 9,000 $0.94 $8,460.00
Disclosure

SEC source: 0001683168-23-006200 · ownership.xml · nonDerivative · entry 1

Calise Chris · CIK 0001824769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,462,315

F1 · balance_after: Includes (i) 942,117 shares of common stock that are issuable under currently exercisable options and (ii) 7,500 shares of common stock that are issuable upon exercise of options that will become exercisable. Does not include 22,500 shares of common stock that are issuable upon exercise of options that are not currently exercisable and will not become exercisable in the next 60 days.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.